---
type: "NewsArticle"
title: "Supplement review finds mixed cognitive signals across Alzheimer’s and MCI trials"
description: "A 29-trial network review found mixed signals across cognitive tests in Alzheimer’s disease and mild cognitive impairment; no supplement significantly improved ADAS-Cog."
resource: "https://nootropikler.com/news/supplements-mci-alzheimer-network-review-2026"
tags: ["nutrition", "cognition", "research"]
timestamp: 2026-10-04T23:57:59Z
language: "en"
---

# Supplement review finds mixed cognitive signals across Alzheimer’s and MCI trials

A 29-trial network review found mixed signals across cognitive tests in Alzheimer’s disease and mild cognitive impairment; no supplement significantly improved ADAS-Cog.

Author: Nootropik News Editorial Team
Published: 2026-10-04T23:57:59Z
Update: 2026-10-04T23:57:59Z
News/source date: 2026-07-23
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

This systematic review and network meta-analysis pooled 29 randomized trials with 2,000 participants who had Alzheimer’s disease or mild cognitive impairment. The authors searched four databases through July 2024. Network comparisons combine direct and indirect evidence, and the included products, trials and cognitive measures varied.

## Findings

The abstract reports that several interventions ranked favorably against placebo on Mini-Mental State Examination scores, including plant extracts, probiotics with selenium, 100-mg phosphatidylserine, spirulina and vitamin B; it also reports a positive estimate for Cosmos caudatus. No supplement significantly improved the Alzheimer’s Disease Assessment Scale–Cognitive Subscale. The difference between these cognitive scales is central to interpreting the review: the results are mixed signals, not a settled treatment effect.

## Limitations and disclosures

The search ended two years before publication, so later trials were not included. Small heterogeneous studies and indirect comparisons make rankings uncertain; full certainty and risk-of-bias details were not available in the abstract. The abstract did not expose complete funding or competing-interest disclosures. The review does not establish supplements as treatment or support replacing clinical care.

## Sources

- [The impact of supplements on cognitive function for Alzheimer's disease or mild cognitive impairment: a systematic review and network meta-analysis](https://doi.org/10.1080/1028415X.2026.2703619) — 2026-07-23
- [PubMed record, PMID 42494057](https://pubmed.ncbi.nlm.nih.gov/42494057/) — 2026-07-23
